Home > Research > Publications & Outputs > Oncolytic viruses-modulated immunogenic cell de...

Research

Associated organisational units

Electronic data

  • Mini review-marked-13-MM

    83.9 KB, Word document

    Available under license: CC BY: Creative Commons Attribution 4.0 International License

Links

Text available via DOI:

Keywords

View graph of relations

Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response

Research output: Contribution to Journal/Magazine › Review article › peer-review

Published
Close
More...
<mark>Journal publication date</mark>15/03/2023
<mark>Journal</mark>Frontiers in cellular and infection microbiology
Volume13
Publication StatusPublished
<mark>Original language</mark>English

Abstract

Recent reports have revealed that oncolytic viruses (OVs) play a significant role in cancer therapy. The infection of OVs such as oncolytic vaccinia virus (OVV), vesicular stomatitis virus (VSV), parvovirus, mammalian reovirus (MRV), human adenovirus, Newcastle disease virus (NDV), herpes simplex virus (HSV), avian reovirus (ARV), Orf virus (ORFV), inactivated Sendai virus (ISV), enterovirus, and coxsackievirus offer unique opportunities in immunotherapy through diverse and dynamic pathways. This mini-review focuses on the mechanisms of OVs-mediated virotherapy and their effects on immunogenic cell death (ICD), apoptosis, autophagy and regulation of the immune system.